Neuro-Oncology Reviews
Volume
25 Number 10
31 May 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 10, 31 May
Guerin JB, Kaufmann TJ, Eckel LJ, Morris JM, Vaubel RA, Giannini
C, Johnson DR.
A Radiologist's Guide to
the 2021 WHO Central Nervous System Tumor Classification: Part
2-Newly Described and Revised Tumor Types.
Radiology.
2023 May 16:221885∟.
doi: 10.1148/radiol.221885∟.
PMID: 37191486∟.
Review˰ ˍ
Titov O, Bykanov A, Pitskhelauri D.
Neurosurgical
skills analysis by machine learning models: systematic
review.
Neurosurg Rev.
2023 May 16;46(1):121∟.
doi: 10.1007/s10143-023-02028-x∟.
PMID: 37191734∟.
Review˰ ˍ
Zaghloul MS, Hunter A, Mostafa AG, Parkes J.
Re-irradiation
for recurrent/progressive pediatric brain tumors: from
radiobiology to clinical outcomes.
Expert
Rev Anticancer Ther. 2023 May 16:1-9∟.
doi: 10.1080/14737140.2023.2215439∟.
PMID: 37194207∟.
Review˰ ˍ
Andrews LJ, Davies P, Herbert C, Kurian KM.
Pre-diagnostic
blood biomarkers for adult glioma.
Front
Oncol. 2023 May 17;13:1163289∟.
doi: 10.3389/fonc.2023.1163289∟.
PMID: 37265788∟.
Review. ˍ
Shahabifard H, Zarei M, Kookli K, Esmalian Afyouni N, Soltani N,
Maghsoodi S, Adili A, Mahmoudi J, Shomali N, Sandoghchian
Shotorbani S.
An updated overview of
the application of CAR-T cell therapy in neurological
diseases.
Biotechnol
Prog. 2023 May 17:e3356∟.
doi: 10.1002/btpr.3356∟.
PMID: 37198722∟.
Review˰ ˍ
Agosti E, Panciani PP, Zeppieri M, De Maria L, Pasqualetti F, Tel
A, Zanin L, Fontanella MM, Ius T.
Tumor
Microenvironment and Glioblastoma Cell Interplay as Promoters of
Therapeutic Resistance.
Biology
(Basel). 2023 May 18;12(5):736∟.
doi: 10.3390/biology12050736∟.
PMID: 37237548∟.
Review. ˍ
Baroni LV, Fernández Ponce N, Freytes C, Maldonado FR,
Pinto N, González Ramos J, Lubieniecki F, Zubizarreta P,
Alderete D.
Closing the gap: National
Argentinian discussion forum on paediatric brain tumours.
Front
Oncol. 2023 May 18;13:1185766∟.
doi: 10.3389/fonc.2023.1185766∟.
PMID: 37274284∟.
Meeting report. ˍ
Ek H, Fagerström Kristensen I, Stenberg L, Kinhult S, Benedek
H, Ek S, Engelholm SA, Engelholm S, Munck Af Rosenschöld
P.
Transitioning from conventional
photon therapy to proton therapy for primary brain tumors.
Acta
Oncol. 2023 May 18:1-9∟.
doi: 10.1080/0284186X.2023.2200150∟.
PMID: 37203198∟.
Review. ˍ
Gillette JS, Wang EJ, Dowd RS, Toms SA.
Barriers
to overcoming immunotherapy resistance in glioblastoma.
Front
Med (Lausanne). 2023 May 18;10:1175507∟.
doi: 10.3389/fmed.2023.1175507∟.
PMID: 37275361∟.
Review. ˍ
Martin KC, Ma C, Yip S.
From Theory to
Practice: Implementing the WHO 2021 Classification of Adult
Diffuse Gliomas in Neuropathology Diagnosis.
Brain
Sci. 2023 May 18;13(5):817∟.
doi: 10.3390/brainsci13050817∟.
PMID: 37239289∟.
Review. ˍ
Di Filippo LD, de Carvalho SG, Duarte JL, Luiz MT, Paes Dutra JA,
de Paula GA, Chorilli M, Conde J.
A
receptor-mediated landscape of druggable and targeted
nanomaterials for gliomas.
Mater
Today Bio. 2023 May 19;20:100671∟.
doi: 10.1016/j.mtbio.2023.100671∟.
PMID: 37273792∟.
Review. ˍ
Duerinck J, Tuyaerts S, Movahedi K, Neyns B.
Overcoming
the immune suppressive nature of glioblastoma by leveraging the
surgical intervention - current status and future
perspectives.
Front
Immunol. 2023 May 19;14:1183641∟.
doi: 10.3389/fimmu.2023.1183641∟.
PMID: 37275902∟.
Review. ˍ
Embring A, Blomstrand M, Asklid A, Nilsson MP, Agrup M, Svärd
AM, Fröjd C, Martinsson U, Fagerström Kristensen I,
Engellau J.
Re-irradiation in
Paediatric Tumours of the Central Nervous System: National
Guidelines from the Swedish Workgroup of Paediatric
Radiotherapy.
Clin
Oncol (R Coll Radiol). 2023 May 19:S0936-6555(23)00185-1∟.
doi: 10.1016/j.clon.2023.05.007∟.
PMID: 37246041∟.
Guidelines˰ ˍ
Rafii S, Kandoussi S, Ghouzlani A, Naji O, Reddy KP, Ullah Sadiqi
R, Badou A.
Deciphering immune
microenvironment and cell evasion mechanisms in human
gliomas.
Front Oncol.
2023 May 19;13:1135430∟.
doi: 10.3389/fonc.2023.1135430∟.
PMID: 37274252∟.
Review. ˍ
Wan S, Zhang G, Liu R, Abbas MN, Cui H.
Pyroptosis,
ferroptosis, and autophagy cross-talk in glioblastoma opens up new
avenues for glioblastoma treatment.
Cell
Commun Signal. 2023 May 19;21(1):115∟.
doi: 10.1186/s12964-023-01108-1∟.
PMID: 37208730∟.
Review. ˍ
*
Yuile A, Wei JQ, Mohan AA, Hotchkiss KM, Khasraw
M.
Interdependencies of the Neuronal,
Immune and Tumor Microenvironment in Gliomas.
Cancers
(Basel). 2023 May 21;15(10):2856∟.
doi: 10.3390/cancers15102856∟.
PMID: 37345193∟.
Review.
ˍ
Baisiwala S, Ko M, Zubair H, Li K, Vivas AC, Everson R, Liau L,
Bari A, Patel KS.
Metastatic secondary
gliosarcoma: patient series.
J
Neurosurg Case Lessons. 2023 May 22;5(21):CASE232∟.
doi: 10.3171/CASE232∟.
PMID: 37218733∟.
Case report, Review. ˍ
Juratli TA, Jungk C, Miller JJ.
Journal
of Neuro Oncology: Diagnostic and therapeutic implications of IDH
mutations in gliomas following the 2021 World Health Organization
classification of CNS tumors.
J
Neurooncol. 2023 May 22;162(3):457-459∟.
doi: 10.1007/s11060-023-04317-3∟.
PMID: 37212938∟.
Review. ˍ
Bernhard C, Reita D, Martin S, Entz-Werle N, Dontenwill
M.
Glioblastoma Metabolism: Insights
and Therapeutic Strategies.
Int
J Mol Sci. 2023 May 23;24(11):9137∟.
doi: 10.3390/ijms24119137∟.
PMID: 37298093∟.
Review. ˍ
Solomou G, Finch A, Asghar A, Bardella C.
Mutant
IDH in Gliomas: Role in Cancer and Treatment Options.
Cancers
(Basel). 2023 May 23;15(11):2883∟.
doi: 10.3390/cancers15112883∟.
PMID: 37296846∟.
Review. ˍ
Bianconi A, Palmieri G, Aruta G, Monticelli M, Zeppa P, Tartara F,
Melcarne A, Garbossa D, Cofano F.
Updates
in Glioblastoma Immunotherapy: An Overview of the Current Clinical
and Translational Scenario.
Biomedicines.
2023 May 24;11(6):1520∟.
doi: 10.3390/biomedicines11061520∟.
PMID: 37371615∟.
Review. ˍ
Sollmann N, Zhang H, Kloth C, Zimmer C, Wiestler B, Rosskopf J,
Kreiser K, Schmitz B, Beer M, Krieg SM.
Modern
preoperative imaging and functional mapping in patients with
intracranial glioma.
Rofo.
2023 May 24∟.
doi: 10.1055/a-2083-8717∟.
PMID: 37224867∟.
Review. ˍ
Yanchu L, Rong P, Rong C, Li Z, Xiaoyan Y, Feng W.
Ozone
therapy for high-grade glioma: an overview.
Front
Oncol. 2023 May 24;13:1161206∟.
doi: 10.3389/fonc.2023.1161206∟.
PMID: 37293584∟.
Review. ˍ
Conarroe CA, Bullock TNJ. Ready for Prime Time?
Dendritic
Cells in High-Grade Gliomas.
Cancers
(Basel). 2023 May 25;15(11):2902∟.
doi: 10.3390/cancers15112902∟.
PMID: 37296865∟.
Review. ˍ
Foster JB, Alonso MM, Sayour E, Davidson TB, Persson ML, Dun MD,
Kline C, Mueller S, Vitanza NA, van der Lugt J.
Translational
considerations for immunotherapy clinical trials in pediatric
neuro-oncology.
Neoplasia.
2023 May 25;42:100909∟.
doi: 10.1016/j.neo.2023.100909∟.
PMID: 37244226∟.
Review. ˍ
Lim J, Kang I, La J, Ku KB, Kang BH, Kim Y, Park WH, Lee
HK.
Harnessing type I
interferon-mediated immunity to target malignant brain
tumors.
Front Immunol.
2023 May 25;14:1203929∟.
doi: 10.3389/fimmu.2023.1203929∟.
PMID: 37304294∟.
Review. ˍ
Qiu Q, Ding X, Chen J, Chen S, Wang J.
Nanobiotechnology-based
treatment strategies for malignant relapsed glioma.
J
Control Release. 2023 May 25:S0168-3659(23)00329-2∟.
doi: 10.1016/j.jconrel.2023.05.016∟.
PMID: 37196900∟.
Review˰ ˍ
Rodriguez A, Kamiya-Matsuoka C, Majd NK.
The
Role of Immunotherapy in the Treatment of Rare Central Nervous
System Tumors.
Curr
Oncol. 2023 May 25;30(6):5279-5298∟.
doi: 10.3390/curroncol30060401∟.
PMID: 37366884∟.
Review.
ˍ
Verso M, Muñoz A, Connors JM.
Ambulatory
cancer patients: who should definitely receive antithrombotic
prophylaxis and who should never receive.
Intern
Emerg Med. 2023 May 25∟.
doi: 10.1007/s11739-023-03306-8∟.
PMID: 37227679∟.
Review˰ ˍ
Wang M, Wang X, Jin X, Zhou J, Zhang Y, Yang Y, Liu Y, Zhang
J.
Cell-based and cell-free
immunotherapies for glioblastoma: current status and future
directions.
Front
Immunol. 2023 May 25;14:1175118∟.
doi: 10.3389/fimmu.2023.1175118∟.
PMID: 37304305∟.
Review. ˍ
Borba LAB, Passos G, Oliveira I.
Liquid
biopsy and tumor DNA/RNA detection in the cerebrospinal fluid of
patients diagnosed with central nervous system glioma - A review
article.
Surg Neurol
Int. 2023 May 26;14:183∟.
doi: 10.25259/SNI_52_2023∟.
PMID: 37292399∟.
Review. ˍ
Lim-Fat MJ, Das S.
Unique molecular,
clinical, and treatment aspects of gliomas in adolescents and
young adults: a review.
J
Neurosurg. 2023 May 26:1-9∟.
doi: 10.3171/2023.4.JNS221800∟.
PMID: 37243561∟.
Review˰ ˍ
Webb MJ, Sener U, Vile RG.
Current
Status and Challenges of Oncolytic Virotherapy for the Treatment
of Glioblastoma.
Pharmaceuticals
(Basel). 2023 May 26;16(6):793∟.
doi: 10.3390/ph16060793∟.
PMID: 37375742∟.
Review.
ˍ
Rao R, Patel A, Hanchate K, Robinson E, Edwards A, Shah S, Higgins
D, Haworth KJ, Lucke-Wold B, Pomeranz Krummel D, Sengupta
S.
Advances in Focused Ultrasound for
the Treatment of Brain Tumors.
Tomography.
2023 May 29;9(3):1094-1109∟.
doi: 10.3390/tomography9030090∟.
PMID: 37368542∟.
Review. ˍ
Ntenti C, Lallas K, Papazisis G.
Clinical,
Histological, and Molecular Prognostic Factors in Childhood
Medulloblastoma: Where Do We Stand?
Diagnostics
(Basel). 2023 May 30;13(11):1915∟.
doi: 10.3390/diagnostics13111915∟.
PMID: 37296767∟.
Review. ˍ
Rončević A, Koruga N, Soldo Koruga A, Rončević
R, Rotim T, Šimundić T, Kretić D, Perić M,
Turk T, Štimac D.
Personalized
Treatment of Glioblastoma: Current State and Future
Perspective.
Biomedicines.
2023 May 30;11(6):1579∟.
doi: 10.3390/biomedicines11061579∟.
PMID: 37371674∟.
Review.
ˍ
Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D,
Mancini S, Carlesi E, Moretti M, Desideri I, Muscas G, Della Puppa
A, Fainardi E.
Conventional and
Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing
Peritumoral Area in Brain Tumor.
Cancers
(Basel). 2023 May 30;15(11):2992∟.
doi: 10.3390/cancers15112992∟.
PMID: 37296953∟.
Review. ˍ
Kardani K, Sanchez Gil J, Rabkin SD.
Oncolytic
herpes simplex viruses for the treatment of glioma and targeting
glioblastoma stem-like cells.
Front
Cell Infect Microbiol. 2023 May 31;13:1206111∟.
doi: 10.3389/fcimb.2023.1206111∟.
PMID: 37325516∟.
Review.
ˍ
Liu Y, Wu M.
Deep
learning in precision medicine and focus on glioma.
Bioeng
Transl Med. 2023 May 31;8(5):e10553∟.
doi: 10.1002/btm2.10553∟.
PMID: 37693051∟.
Review. ˍ
Shapiro JA, Gaonkar KS, Spielman SJ, Savonen CL, Bethell CJ, Jin
R, Rathi KS, Zhu Y, Egolf LE, Farrow BK, Miller DP, Yang Y,
Koganti T, Noureen N, Koptyra MP, Duong N, Santi M, Kim J, Robins
S, Storm PB, Mack SC, Lilly JV, Xie HM, Jain P, Raman P, Rood BR,
Lulla RR, Nazarian J, Kraya AA, Vaksman Z, Heath AP, Kline C,
Scolaro L, Viaene AN, Huang X, Way GP, Foltz SM, Zhang B, Poetsch
AR, Mueller S, Ennis BM, Prados M, Diskin SJ, Zheng S, Guo Y,
Kannan S, Waanders AJ, Margol AS, Kim MC, Hanson D, Van Kuren N,
Wong J, Kaufman RS, Coleman N, Blackden C, Cole KA, Mason JL,
Madsen PJ, Koschmann CJ, Stewart DR, Wafula E, Brown MA, Resnick
AC, Greene CS, Rokita JL, Taroni JN; Children’s Brain Tumor
Network; Pacific Pediatric Neuro-Oncology Consortium.
OpenPBTA:
The Open Pediatric Brain Tumor Atlas.
Cell
Genom. 2023 May 31;3(7):100340∟.
doi: 10.1016/j.xgen.2023.100340∟.
PMID: 37492101∟.
Tumor atlas. ˍ
Vallejo FA, Sigdel G, Veliz EA, Leblanc RM, Vanni S, Graham
RM.
Carbon Dots in Treatment of
Pediatric Brain Tumors: Past, Present, and Future Directions.
Int
J Mol Sci. 2023 May 31;24(11):9562∟.
doi: 10.3390/ijms24119562∟.
PMID: 37298513∟.
Review. ˍ
Zaidi SE, Moelker E, Singh K, Mohan A, Salgado MA, Essibayi MA,
Hotchkiss K, Shen S, Lee W, Sampson J, Khasraw M.
Novel
Immunotherapeutic Approaches for the Treatment of
Glioblastoma.
BioDrugs.
2023 May 31∟.
doi: 10.1007/s40259-023-00598-2∟.
PMID: 37256535∟.
Review˰ ˍ